Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CRBU

Caribou Biosciences Inc

Sep 20 • 04:00PM ET

2.07

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN IBB DFAT SCHA VTWO DFAC IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.39	Insider Own	11.57%	Shs Outstand	88.45M	Perf Week	-2.36%
Market Cap	187.05M	Forward P/E	-	EPS next Y	-2.05	Insider Trans	0.00%	Shs Float	79.91M	Perf Month	-7.17%
Income	-123.44M	PEG	-	EPS next Q	-0.45	Inst Own	60.43%	Short Float	14.25%	Perf Quarter	20.35%
Sales	33.11M	P/S	5.65	EPS this Y	-28.53%	Inst Trans	8.97%	Short Ratio	7.05	Perf Half Y	-60.57%
Book/sh	3.44	P/B	0.60	EPS next Y	-15.37%	ROA	-34.17%	Short Interest	11.38M	Perf Year	-60.72%
Cash/sh	2.90	P/C	0.71	EPS next 5Y	14.50%	ROE	-42.57%	52W Range	1.50 - 8.33	Perf YTD	-63.87%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-37.16%	ROI	-36.74%	52W High	-75.15%	Beta	2.29
Dividend TTM	-	Quick Ratio	8.75	Sales past 5Y	71.11%	Gross Margin	82.95%	52W Low	38.00%	ATR (14)	0.16
Dividend Ex-Date	-	Current Ratio	8.75	EPS Y/Y TTM	23.67%	Oper. Margin	-427.56%	RSI (14)	51.40	Volatility	7.47% 7.78%
Employees	158	Debt/Eq	0.09	Sales Y/Y TTM	132.34%	Profit Margin	-372.78%	Recom	1.25	Target Price	15.62
Option/Short	Yes / Yes	LT Debt/Eq	0.08	EPS Q/Q	13.17%	Payout	-	Rel Volume	0.76	Prev Close	2.07
Sales Surprise	13.69%	EPS Surprise	8.30%	Sales Q/Q	-7.75%	Earnings	Aug 06 AMC	Avg Volume	1.62M	Price	2.07
SMA20	1.83%	SMA50	-2.45%	SMA200	-48.74%	Trades		Volume	1,223,538	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-24	Downgrade	Evercore ISI	Outperform → In-line	$13 → $3
Nov-08-23	Initiated	Cantor Fitzgerald	Neutral
Oct-31-23	Initiated	Evercore ISI	Outperform	$13
Jul-11-23	Initiated	Truist	Buy	$23
Feb-18-22	Initiated	RBC Capital Mkts	Outperform	$22
Dec-01-21	Initiated	Oppenheimer	Outperform	$36
Nov-30-21	Initiated	H.C. Wainwright	Buy	$28
Nov-15-21	Upgrade	Citigroup	Neutral → Buy	$27
Aug-17-21	Initiated	SVB Leerink	Outperform	$32
Aug-17-21	Initiated	Citigroup	Neutral	$27
Aug-17-21	Initiated	BofA Securities	Buy	$30

Show Previous Ratings

Sep-03-24 08:00AM	Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AML (GlobeNewswire) -8.33%
Aug-26-24 04:00PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-12-24 08:00AM	Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer (GlobeNewswire)
Aug-06-24 06:50PM	Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
10:00AM	Loading…
10:00AM	Caribou Biosciences, Inc. (CRBU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release (Zacks)
Jul-17-24 07:45AM	Caribou lays off staff; Roche walks away from Relay (BioPharma Dive)
Jul-09-24 08:00AM	Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board (GlobeNewswire)
Jun-02-24 07:00PM	Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-30-24 04:01PM	Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences (GlobeNewswire)
May-12-24 04:00PM	3 Underappreciated Stocks That Could 10x in 10 Years (InvestorPlace)
May-09-24 05:23AM	Truist Adjusts Price Target on Caribou Biosciences to $19 From $21, Maintains Buy Rating (MT Newswires)
May-07-24 10:55PM	CRBU Stock Earnings: Caribou Biosciences Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -6.17%
05:25PM	Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
04:05PM	Loading…
May-01-24 04:05PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-27-24 06:00AM	Bragar Eagel & Squire is Investigating Certain Officers and Directors of Caribou, Verrica, and Playstudios on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm (GlobeNewswire)
Apr-24-24 10:00AM	Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
Apr-15-24 09:00AM	Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) (GlobeNewswire)
Apr-04-24 04:00PM	Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus (GlobeNewswire)
Mar-14-24 12:00PM	All You Need to Know About Caribou Biosciences, Inc. (CRBU) Rating Upgrade to Buy (Zacks)
Mar-13-24 03:32PM	11 Oversold NASDAQ Stocks To Buy Right Now (Insider Monkey) +11.55%
Mar-12-24 12:37PM	Why Caribou Biosciences Stock Is Crashing Today (Motley Fool) -30.47%
Mar-11-24 04:05PM	Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-05-24 04:30PM	Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
Feb-26-24 01:14PM	12 $10 Stocks That Will Triple (Insider Monkey) +6.92%
06:45AM	Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold (Motley Fool)
Feb-23-24 11:25PM	Steven Cohen's Point72 Adds Caribou Biosciences Inc to Its Portfolio (GuruFocus.com)
Feb-15-24 04:05PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-12-24 08:30AM	2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare (Motley Fool)
08:45AM	Loading…
Jan-15-24 08:45AM	3 Biotech Stocks You Can Buy and Hold for the Next Decade (Motley Fool)
Jan-07-24 11:00AM	Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024 (GlobeNewswire)
Dec-13-23 07:26AM	5 Things to Know Before The Stock Market Opens (Investopedia)
05:20AM	3 Gene-Editing Stocks With the Potential to Mint Millionaires (InvestorPlace)
Dec-12-23 04:02PM	Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024 (GlobeNewswire)
Dec-08-23 12:00PM	Caribou Biosciences, Inc. (CRBU) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Dec-06-23 09:55AM	Wall Street Analysts Believe Caribou Biosciences, Inc. (CRBU) Could Rally 285.29%: Here's is How to Trade (Zacks)
Nov-20-23 09:55AM	Does Caribou Biosciences, Inc. (CRBU) Have the Potential to Rally 321.46% as Wall Street Analysts Expect? (Zacks) +6.51%
Nov-07-23 04:00PM	Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) -5.03%
Nov-06-23 08:00AM	Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory Board (GlobeNewswire) +14.11%
Nov-01-23 04:05PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-20-23 05:00AM	2 Top Growth Stocks to Buy Right Now Without Hesitation (Motley Fool)
Oct-18-23 08:00AM	Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (GlobeNewswire) -6.00%
Oct-11-23 06:00AM	2 Exciting Biotech Stocks to Buy With Less Than $10 (Motley Fool)
Oct-10-23 05:40AM	A Bull Market Is Coming: 1 Beaten-Down Growth Stock You Could Regret Not Buying on the Dip (Motley Fool)
Oct-05-23 10:07AM	Avoid Big Losses With Biotech Stocks by Paying Attention to These 2 Things (Motley Fool)
Sep-27-23 08:30AM	2 Magnificent Growth Stocks to Buy On the Dip (Motley Fool)
08:00AM	Caribou Biosciences Appoints Reigin Zawadzki as Chief People Officer (GlobeNewswire)
Sep-23-23 08:45AM	1 Gene Editing Stock to Buy Now, and 1 to Sell (Motley Fool)
Aug-29-23 04:00PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-24-23 05:58AM	3 Clever Tricks to Find Winning Biotech Stocks (Motley Fool)
Aug-15-23 04:08PM	Robert Bruce's Q2 2023 13F Filing Update: Key Trades and Portfolio Overview (GuruFocus.com)
03:08PM	Is Caribou Biosciences (CRBU) Stock Outpacing Its Medical Peers This Year? (Zacks)
Aug-08-23 05:15PM	Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +5.81%
04:00PM	Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Jul-28-23 08:30AM	3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond (Motley Fool) +7.05%
Jul-22-23 09:45AM	This 1 Innovation Could Make These 2 Biotechs Soar by 2030 (Motley Fool)
Jul-21-23 10:00AM	Got $1,000? Buying Caribou Biosciences Stock Right Now Could Be a Brilliant Move in 5 Years (Motley Fool)
Jul-20-23 11:35AM	2 Growth Stocks That Could Rocket 81% to 233% Higher, According to Wall Street (Motley Fool)
Jul-19-23 09:30AM	Caribou Biosciences, Inc. (CRBU) Just Overtook the 200-Day Moving Average (Zacks)
Jul-17-23 05:03PM	2 Stocks I'm Buying on the Dip This Week (Motley Fool) +9.86%
Jul-14-23 11:27AM	Caribou Biosciences Raises $125M Via Equity Just One Week After Pfizer Invested $25M (Benzinga) -22.60%
Jul-13-23 11:15PM	Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering (GlobeNewswire)
04:03PM	Caribou Biosciences Announces Proposed Public Offering of Common Stock (GlobeNewswire)
04:01PM	CORRECTED-Caribou's cell therapy shows promise in early-stage cancer study (July 13) (Reuters)
04:01PM	Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL (GlobeNewswire)
09:30AM	2 Magnificient Growth Stocks to Buy in July (Motley Fool)
Jul-12-23 09:40AM	Is Caribou Biosciences (CRBU) Outperforming Other Medical Stocks This Year? (Zacks)
Jul-11-23 09:55AM	How Much Upside is Left in Caribou Biosciences, Inc. (CRBU)? Wall Street Analysts Think 316.72% (Zacks) +15.81%
Jul-07-23 08:14AM	Caribou Biosciences (CRBU) Soars on $25M Investment by Pfizer (Zacks) +22.22%
Jul-06-23 11:03PM	Caribou Biosciences, Inc. (CRBU) Surges 45.6%: Is This an Indication of Further Gains? (Zacks) +45.59%
01:56PM	Rebel's Edge - July 6: $UPST, $GENI, $CRBU, and the Atlanta Braves (TheStreet.com)
11:54AM	Why Shares of Caribou Biosciences Are Skyrocketing Today (Motley Fool)
10:43AM	Pfizer makes equity investment in Caribou Biosciences (Reuters)
08:00AM	Caribou Biosciences Announces $25 Million Equity Investment from Pfizer (GlobeNewswire)
Jun-15-23 12:53PM	The past year for Caribou Biosciences (NASDAQ:CRBU) investors has not been profitable (Simply Wall St.)
May-31-23 04:00PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-16-23 11:25AM	Caribou Biosciences, Inc. (NASDAQ:CRBU) is largely controlled by institutional shareholders who own 66% of the company (Simply Wall St.) -5.56%
May-09-23 05:15PM	Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +6.82%
04:00PM	Caribou Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-08-23 09:00AM	Caribou Biosciences Announces Appointment of Stephen J. Schuster, MD, to its Scientific Advisory Board (GlobeNewswire)
May-01-23 04:00PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire) -5.44%
Apr-26-23 02:10PM	12 Gene Editing Stocks With the Best Long-Term Potential (Insider Monkey)
Apr-17-23 01:30PM	Caribou Biosciences Presents New Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the 2023 AACR Annual Meeting (GlobeNewswire)
Apr-04-23 08:00AM	Caribou Biosciences Announces FDA Granted Fast Track Designation to CB-011, an Allogeneic CAR-T Cell Therapy for Relapsed or Refractory Multiple Myeloma (GlobeNewswire)
Mar-29-23 08:00AM	Caribou Biosciences Initiates Dose Expansion Portion of CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients (GlobeNewswire) +9.30%
08:00AM	Caribou Biosciences Announces Dosing of First Patient in the CaMMouflage Phase 1 Trial of CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Multiple Myeloma (GlobeNewswire)
Mar-11-23 07:31AM	Caribou Biosciences Full Year 2022 Earnings: Beats Expectations (Simply Wall St.)
Mar-09-23 07:25PM	Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -6.13% -5.99%
05:09PM	Caribou Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-08-23 04:05PM	Caribou Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference (GlobeNewswire)
Mar-07-23 12:10PM	Here's Why We're Not Too Worried About Caribou Biosciences' (NASDAQ:CRBU) Cash Burn Situation (Simply Wall St.)
Feb-01-23 04:05PM	Caribou Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-06-23 11:01AM	Investors in Caribou Biosciences (NASDAQ:CRBU) from a year ago are still down 46%, even after 11% gain this past week (Simply Wall St.)
Jan-03-23 04:05PM	Caribou Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +5.25% +7.72%
Dec-12-22 08:01AM	Caribou Biosciences Reports CB-010 ANTLER Phase 1 Trial Progress (GlobeNewswire) -9.03%
08:00AM	Caribou Biosciences Selects ROR1 as the Target for CB-020, an iPSC-derived Allogeneic CAR-NK Cell Therapy (GlobeNewswire)
Dec-07-22 09:52AM	Positive week for Caribou Biosciences, Inc. (NASDAQ:CRBU) institutional investors who lost 50% over the past year (Simply Wall St.)
Nov-29-22 09:00AM	Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track Designations to CB-010, an Allogeneic Anti-CD19 CAR-T Cell Therapy (GlobeNewswire)
Nov-21-22 09:00AM	Caribou Biosciences Announces FDA Clearance of IND Application for CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Multiple Myeloma (GlobeNewswire)

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kanner Steven	Chief Scientific Officer	Feb 06 '24	Option Exercise	2.69	30,577	82,252	354,037	Feb 08 05:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CRBU

Caribou Biosciences Inc

Upgrade your FINVIZ experience